PharmaShots | Incisive News in 3 Shots

Subscribe Now

arrowhead pharmaceuticals

Arrowhead Pharmaceuticals Commences P-I/IIa Trial of ARO-INHBE to Treat Obesity

Arrowhead Pharmaceuticals Commences P-I/IIa Trial of ARO-INHBE to Treat Obesity

December 24, 2024

Arrowhead Pharmaceuticals Reports the P-III (PALISADE) Trial Results of Plozasiran to Treat Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals Reports the P-III (PALISADE) Trial Results of Plozasiran to Treat Familial Chylomicronemia Syndrome (FCS...

September 3, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us